The FDA has approved garadacimab-gxii for prophylactic use in patients aged 12 years and older with hereditary angioedema, according to a press release from CSL Behring. The approval was based on ...

These ailments have accompanied humanity for thousands, even millions, of years—and they’re not done with us yet.

06.01.2023: Opinions - Uncertainty surrounding possible thromboembolic events may prevent widespread use of tranexamic acid in surgery.

Find the latest Cabaletta Bio, Inc. (CABA) stock quote, history, news and other vital information to help you with your stock trading and investing.

Introduction Pre-exposure prophylaxis (PrEP) is highly effective at preventing HIV acquisition, but coverage remains low in high prevalence settings. Initiating and continuing PrEP via online ...

Explore this issue of The New England Journal of Medicine (Vol. 0 No. 0).

Successfully treated NTM disease should not preclude low-dose macrolide monotherapy. If there is any clinical suspicion of possible NTM disease, patients should be screened via examination of sputum ...

Objective: To study the efficacy of isoniazid prophylaxis (INHP) in patients with systemic lupus erythematosus (SLE) receiving long term glucocorticosteroid treatment. Patients and methods: Treatment ...

04.03.2011: Review article - .Background. Pressure ulcers (decubitus) occur very frequently and are found in 10 – 20 % of patients in health institutions. Health personnel should be well acquainted ...